Anti-inflammatory Effects of Oroxylin A on RAW 264.7 Mouse Macrophages Induced with Polyinosinic-polycytidylic Acid
Overview
Authors
Affiliations
Oroxylin A (5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one; Baicalein 6-methyl ether) is an active flavonoid compound originally isolated from Scutellaria radix, which has been used to treat pulmonary infection in Korea, China, and Japan. Oroxylin A is known to possess dopamine reuptake inhibitor activity. However, the effects of oroxylin A on virus-induced macrophages has not been fully elucidated. In the present study, the anti-inflammatory effects of oroxylin A on double-stranded RNA-induced macrophages were examined. Production of nitric oxide (NO), various cytokines, as well as calcium release and the mRNA expression of signal transducer and activator of transcription 1 (STAT1) in dsRNA polyinosinic-polycytidylic acid (PIC)-induced RAW 264.7 mouse macrophages were evaluated. Oroxylin A restored the cell viability in PIC-induced RAW 264.7 mouse macrophages at concentrations of up to 50 µM. Additionally, oroxylin A significantly inhibited the production of nitric oxide (NO), interleukin (IL)-1α, IL-1β, IL-6, IL-10, interferon gamma-induced protein 10, granulocyte-colony stimulating factor (CSF), granulocyte macrophage-CSF, leukemia inhibitory factor (IL-6 class cytokine), lipopolysaccharide-induced CXC chemokine (LIX), monocyte chemoattractant protein 1, macrophage inflammatory protein (MIP)-1α, MIP-1β, MIP-2, Regulated on Activation, Normal T Expressed and Secreted, tumor necrosis factor-α, and vascular endothelial growth factor as well as calcium release and the mRNA expression of STAT1 in PIC-induced RAW 264.7 cells (P<0.05). Thus, the present results suggest that oroxylin A has anti-inflammatory properties, associated with its inhibition of NO, cytokines, chemokines and growth factors in PIC-induced macrophages via the calcium-STAT pathway.
Panomai P, Thapphasaraphong S, Nualkaew N Plants (Basel). 2024; 13(15).
PMID: 39124228 PMC: 11314318. DOI: 10.3390/plants13152110.
Lambona C, Zwergel C, Valente S, Mai A J Med Chem. 2024; 67(3):1662-1689.
PMID: 38261767 PMC: 10859967. DOI: 10.1021/acs.jmedchem.3c01979.
Wang Z, Zhan J, Gao H Front Immunol. 2023; 13:1015271.
PMID: 36618410 PMC: 9816407. DOI: 10.3389/fimmu.2022.1015271.
Anticancer potential of oroxylin A: from mechanistic insight to synergistic perspectives.
Tuli H, Garg V, Kumar A, Aggarwal D, Anand U, Parashar N Naunyn Schmiedebergs Arch Pharmacol. 2022; 396(2):191-212.
PMID: 36214865 DOI: 10.1007/s00210-022-02298-0.
Flavonoids as Potential Anti-Inflammatory Molecules: A Review.
Al-Khayri J, Sahana G, Nagella P, Joseph B, Alessa F, Al-Mssallem M Molecules. 2022; 27(9).
PMID: 35566252 PMC: 9100260. DOI: 10.3390/molecules27092901.